Dexmedetomidine Versus Ketamine Versus Magnesium Sulfate for the Prevention of Emergence Agitation Following Sevoflurane Induced Anesthesia in Cardiac Catheterization in Pediatrics

• Status: Recruiting
• Trial end date: 2024-05-01
• Target enrollment: 0
• Participant gender: All

Summary

Emergence agitation (EA) is a post-operative behavioral disturbance was first reported in early 1960s. EA is a term used to describe non purposeful restlessness and agitation, thrashing, crying or moaning, disorientation and incoherence during early stage of recovering from general anesthesia in children, especially those receiving sevoflurane. Generally, the incidence of EA following sevoflurane anesthesia varies from 10% to 66% and is more common in pre-school children. EA is generally short lived without obvious aftereffect. However, it still accompanies with risk of self-injury, and requires extra nursing care, which may delay the discharge and increase the cost of medical care Emergence agitation is diagnosed by a final composite score of greater than or equal to 10 on the Pediatric Anesthesia Emergence Delirium Scale (PAED).(

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Treatments: Dexmedetomidine; Ketamine

Criteria

Inclusion Criteria:

• ASA physical status II

• ages from 2-5 years.

• weight more than 6 kg.

• scheduled for cardiac catheterization procedure not exceeding 3 hours.

Exclusion Criteria:

• psychological disorder or cognitive delay.

• chronic or acute intake of any sedative drug or anticonvulsant drugs.

• Any neurological condition that will limit ability to communicate with, or understand a practitioner.

• those with coexisting renal diseases , any reported allergy to the given medications.

• legal guardian refusal .